NCT04895150 is a clinical trial in Primary Ciliary Dyskinesia, sponsored by Gazi University.

Who is sponsoring NCT04895150?

NCT04895150 is sponsored by Gazi University.

What condition does NCT04895150 study?

NCT04895150 studies Primary Ciliary Dyskinesia.

Is NCT04895150 still recruiting?

NCT04895150 is currently completed. Last updated 19 May 2022.

Last reviewed 2022-05-19 · How we verify

NCT04895150

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Upper Extremity Exercise Capacity, Muscle Oxygenation, Balance in Patients With Primary Ciliary Dyskinesia

Completed Last updated 19 May 2022

What this trial tests

trial in Primary Ciliary Dyskinesia in 54 participants. Completed in 15 May 2022.

Timeline

1 June 2021

Primary endpoint
30 April 2022

15 May 2022

Quick facts

Lead sponsor	Gazi University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	54
Start date	1 June 2021
Primary completion	30 April 2022
Estimated completion	15 May 2022
Sites	2 locations across Turkey (Türkiye)

Conditions studied

Primary Ciliary Dyskinesia — all drugs for Primary Ciliary Dyskinesia →

Sponsor

Gazi University

Who can join

Adults 6 to 18, any sex, with Primary Ciliary Dyskinesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main aim of the study is to evaluate upper extremity exercise capacity and muscle oxygenation in patients with primary ciliary dyskinesia. The secondary aim of the study is to evaluate respiratory function, respiratory muscle strength and endurance, peripheral muscle strength, balance, physical activity level and quality of life in patients with primary ciliary dyskinesia and compare all parameters with healthy controls.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Upper Extremity Exercise Capacity and Muscle Oxygenation in Patients With Primary Ciliary Dyskinesia.
Mutlu Ş, Boşnak Güçlü M, Şişmanlar Eyüboğlu T, Aslan AT. · · 2025 · cited 1× · PMID 39785198 · DOI 10.1002/ppul.27470
Balance Impairment, Muscle Oxygenation, and Functional Exercise Capacity in Patients With Primary Ciliary Dyskinesia.
Mutlu Kayaarslan Ş, Boşnak Güçlü M, Şişmanlar Eyüboğlu T, Aslan AT. · · 2026 · PMID 41928622 · DOI 10.1002/ppul.71605

Verify or expand the search:

Other recruiting trials for Primary Ciliary Dyskinesia

Currently open trials in the same condition.

NCT07274631 — A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine · recruiting
NCT07029594 — Thermal Spa Treatment and Improvement of Primary Ciliary Dyskinesia · NA · recruiting
NCT07288827 — Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia · NA · recruiting
NCT05685186 — A Longitudinal, Observational Study of Primary Ciliary Dyskinesia in Adults · active not recruiting
NCT04602481 — Living With Primary Ciliary Dyskinesia (Living With PCD) · recruiting

Other Gazi University trials

Trials by the same sponsor.

NCT07500857 — Gamification in Stoma Care Education for Nursing Students · NA · not yet recruiting
NCT07471737 — Patient Safety and Medical Errors in Nursing Education: Learning by Doing and Experiencing With Simulated Patients · NA · not yet recruiting
NCT07440563 — Auricular Vagus Nerve Stimulation Combined With Rehabilitation in Parkinson's Disease · NA · enrolling by invitation
NCT07496398 — Median and Ulnar Nerve Function in Tattoo Artists · recruiting
NCT07471386 — Adjunctive Keratinized Mucosa Augmentation in Peri-Implantitis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04895150 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gazi University
Last refreshed: 19 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04895150.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing